4167 松瑞藥本益比(PER)
| 年度/月份 | 本益比(倍) | 月收盤價 |
|---|
| 2026/05 | 12.93 | 18.75 |
| 2026/04 | 13.07 | 18.95 |
| 2026/03 | 14.45 | 20.95 |
| 2026/02 | 13.07 | 18.95 |
| 2026/01 | 14.28 | 20.70 |
| 2025/12 | 12.69 | 18.40 |
| 2025/11 | 12.55 | 18.20 |
| 2025/10 | 11.79 | 17.10 |
| 2025/09 | 12.31 | 17.85 |
| 2025/08 | 12.90 | 18.70 |
| 2025/07 | 11.88 | 18.65 |
| 2025/06 | 12.13 | 19.05 |
| 2025/05 | 13.66 | 21.45 |
| 2025/04 | 33.77 | 19.25 |
| 2025/03 | 33.68 | 19.20 |
| 2025/02 | 34.74 | 19.80 |
| 2025/01 | 35.80 | 20.05 |
| 2024/12 | 36.43 | 20.40 |
| 2024/11 | 36.96 | 20.70 |
| 2024/10 | 59.46 | 22.00 |
| 2024/09 | 57.84 | 21.40 |
| 2024/08 | 62.57 | 23.15 |
| 2024/07 | 70.00 | 22.40 |
| 2024/06 | 79.69 | 25.50 |
| 2024/05 | 66.41 | 21.25 |
| 2024/04 | 237.78 | 21.40 |
| 2024/03 | 217.22 | 19.55 |
| 2024/02 | 223.33 | 20.10 |
| 2024/01 | -117.65 | 20.00 |
| 2023/12 | -132.06 | 22.45 |
| 2023/11 | -121.18 | 20.60 |
| 2023/10 | 61.00 | 18.30 |
| 2023/09 | 58.33 | 17.50 |
| 2023/08 | 61.17 | 18.35 |
| 2023/07 | 63.89 | 17.25 |
| 2023/06 | 68.52 | 18.50 |
| 2023/05 | 64.44 | 17.40 |
| 2023/04 | 166.82 | 18.35 |
| 2023/03 | 171.82 | 18.90 |
| 2023/02 | 186.36 | 20.50 |
| 2023/01 | 144.67 | 21.70 |
| 2022/12 | 165.33 | 24.80 |
| 2022/11 | 126.00 | 18.90 |
| 2022/10 | -34.36 | 16.15 |
| 2022/09 | -37.87 | 17.80 |
| 2022/08 | -41.49 | 19.50 |
| 2022/07 | -39.51 | 16.20 |
| 2022/06 | -42.93 | 17.60 |
| 2022/05 | -40.61 | 16.65 |
| 2022/04 | 638.33 | 19.15 |
| 2022/03 | 606.67 | 18.20 |
| 2022/02 | 571.67 | 17.15 |
| 2022/01 | 39.77 | 17.10 |
| 2021/12 | 44.42 | 19.10 |
| 2021/11 | 45.35 | 19.50 |
| 2021/10 | 26.22 | 20.45 |
| 2021/09 | 26.22 | 20.45 |
| 2021/08 | 30.19 | 23.55 |
| 2021/07 | 31.11 | 25.20 |
| 2021/06 | 33.33 | 27.00 |
| 2021/05 | 35.56 | 28.80 |
| 2021/04 | 34.66 | 30.50 |
| 2021/03 | 33.86 | 29.80 |
| 2021/02 | 35.17 | 30.95 |
| 2021/01 | - | 26.75 |